CLSI CLSI On Demand: June 2024 Education Session
June 2024 Education Session: Exploring Beta-Lactam Combination Agents: Opportunities, Gaps, and Challenges?
Date: June 22, 2024
Explore the challenges and successes of using beta-lactam combination agents from three different perspectives, including the pharmaceutical industry, the laboratory, and clinical practice. This session will delve into the development process of beta-lactam combination agents in addition to laboratory requests and QC issues. The successes and failures of using beta-lactam combination agents in clinical practice will also be discussed.
Register for this free course to claim 1.5 P.A.C.E. credits from the June 2024 education session and receive access to the on-demand recording and slides.
Speakers:
Greg Moeck, PhD, Senior Vice President, Microbiology at Venatorx Pharmaceuticals, Inc.
Romney Humphries, PhD, D(ABMM), M(ASCP), Professor, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center
Andrew Fratoni, PharmD, Associate Director, Clinical and Laboratory Studies, Hartford Hospital
Stella Antonara, PhD, D(ABMM), Medical Director of Microbiology, OhioHealth
Earn 1.5 P.A.C.E.®️ credits.
Member price:
List Price:Details
Date of Webinar: June 22, 2024
CLSI CLSI On Demand: June 2024 Education Session Additional Details
Learning Objectives
- Describe the process in development of beta-lactam combination agents.
- Recognize requests that laboratories receive for testing these agents.
- Identify challenges laboratories face with QC issues when testing beta-lactam combination agents.
- Summarize the success and failures of using beta-lactam combination agents in clinical practice.
Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.